261 related articles for article (PubMed ID: 32192002)
1. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
[No Abstract] [Full Text] [Related]
2. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
Pączek S; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
Anticancer Res; 2021 Mar; 41(3):1421-1428. PubMed ID: 33788733
[TBL] [Abstract][Full Text] [Related]
4. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients.
Łukaszewicz-Zając M; Pączek S; Muszyński P; Kozłowski M; Mroczko B
Clin Exp Med; 2019 May; 19(2):191-199. PubMed ID: 30820705
[TBL] [Abstract][Full Text] [Related]
5. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
6. CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer.
Zajkowska M; Dulewicz M; Kulczyńska-Przybik A; Safiejko K; Juchimiuk M; Konopko M; Kozłowski L; Mroczko B
Sci Rep; 2023 Oct; 13(1):17688. PubMed ID: 37848726
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
Elessawi DF; Alkady MM; Ibrahim IM
Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
[TBL] [Abstract][Full Text] [Related]
8. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
[TBL] [Abstract][Full Text] [Related]
9. Serum Expression of
Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
[TBL] [Abstract][Full Text] [Related]
10. Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer.
Zajkowska M; Kulczyńska-Przybik A; Dulewicz M; Safiejko K; Juchimiuk M; Konopko M; Kozłowski L; Mroczko B
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204490
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
12. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
13. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.
Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378
[TBL] [Abstract][Full Text] [Related]
14. The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients.
Zajkowska M; Dulewicz M; Kulczyńska-Przybik A; Safiejko K; Juchimiuk M; Konopko M; Kozłowski L; Mroczko B
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407400
[TBL] [Abstract][Full Text] [Related]
15. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
16. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
17. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
Ding D; Yao Y; Yang C; Zhang S
Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
[TBL] [Abstract][Full Text] [Related]
18. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
20. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
